methyl 2-((3-azabicyclo[3.1.0]hexan-3-yl)methyl)-3-methylbut-2-enoate

Catalog No. :
ACRQOL459
CAS No. :
2940936-69-4
Molecular Formula :
C12H19NO2
Molecular Weight :
209.29

IUPAC Name:methyl 2-((3-azabicyclo[3.1.0]hexan-3-yl)methyl)-3-methylbut-2-enoate

methyl 2-((3-azabicyclo[3.1.0]hexan-3-yl)methyl)-3-methylbut-2-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$257.00Login to see priceInquiryInquiry
250mg95%$429.00Login to see priceInquiryInquiry
500mg95%$614.00Login to see priceInquiryInquiry
1g95%$877.00Login to see priceInquiryInquiry
5g95%$2632.00Login to see priceInquiryInquiry
10g95%$4475.00Login to see priceInquiryInquiry
25g95%$8774.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl 2-((3-azabicyclo[3.1.0]hexan-3-yl)methyl)-3-methylbut-2-enoate
IUPAC Namemethyl 2-((3-azabicyclo[3.1.0]hexan-3-yl)methyl)-3-methylbut-2-enoate
Molecular FormulaC12H19NO2
Molecular Weight209.29
SMILESCOC(=O)C(CN1CC2CC2C1)=C(C)C
InChI KeyMTBMPGRPOHFCFK-UHFFFAOYSA-N
Synonymmethyl 2-(3-azabicyclo[3.1.0]hexan-3-ylmethyl)-3-methyl-but-2-enoate
CAS No.2940936-69-4

Synthetic Route by SureRoute

1. ACRQOL459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDCI123 route compound structure diagram
    ACPDCI123285-59-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRQOL459 route product structure diagram
    ACRQOL4592940936-69-4
Inquiry

2. ACRQOL459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDCI123 route compound structure diagram
    ACPDCI123285-59-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACRQOL459 route product structure diagram
    ACRQOL4592940936-69-4
Inquiry

Comments (0)